Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia - Osterborg, A; Dyer, MJS; Bunjes, D; Pangalis, GA; Bastion, Y; Catovsky, D; Mellstedt, H; Rankin, E; Tsekouras, C; Cavalli, F; Sessa, C; Huhn, D; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997)